• Asthma, Allergy and Immunologist Dr. Smith on BIOFIRE Multiplex PCR Testing

  • 2022/06/13
  • 再生時間： 13 分
  • ポッドキャスト

Asthma, Allergy and Immunologist Dr. Smith on BIOFIRE Multiplex PCR Testing

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Join Dr. Christopher Smith as he talks with Connie Zellner, Medical Education Liaison with bioMérieux, about his decision to adopt the BIOFIRE multiplex respiratory panel and how it has helped him in his asthma and allergy clinic.

    This podcast was sponsored by bioMerieux.

    More about the power of PCR diagnostic testing in point-of-care clinics here.

    This product has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA for use by authorized laboratories; this product has been authorized only for the detection and differentiation of nucleic acid of SARS-CoV-2 from multiple respiratory viral and bacterial organisms; and, the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
    続きを読む 一部表示

あらすじ・解説

Join Dr. Christopher Smith as he talks with Connie Zellner, Medical Education Liaison with bioMérieux, about his decision to adopt the BIOFIRE multiplex respiratory panel and how it has helped him in his asthma and allergy clinic.

This podcast was sponsored by bioMerieux.

More about the power of PCR diagnostic testing in point-of-care clinics here.

This product has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA for use by authorized laboratories; this product has been authorized only for the detection and differentiation of nucleic acid of SARS-CoV-2 from multiple respiratory viral and bacterial organisms; and, the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
続きを読む 一部表示

Asthma, Allergy and Immunologist Dr. Smith on BIOFIRE Multiplex PCR Testingに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。